Pathophysiology of radiation-induced growth hormone deficiency: efficacy and safety of GH replacement.
AffiliationDepartment of Endocrinology, Christie Hospital NHS Trust, Wilmslow Road, Withington, Manchester M20 4BX, United Kingdom.
MetadataShow full item record
AbstractRadiation-induced growth hormone deficiency (GHD) is primarily due to hypothalamic damage. GH secretion by the pituitary may be affected either secondary to some degree of quantitative deprivation of hypothalamic input or, if the radiation dose is high enough, by direct pituitary damage. As a consequence, the neurosecretory profile of GH secretion in an irradiated patient remains pulsatile and qualitatively intact. The frequency of pulse generation is unaffected, but the amplitude of the GH pulses is markedly reduced. Over the last 25 years, the final heights achieved by children receiving GH replacement for radiation-induced GHD have improved; these improvements are attributable to refinements in GH dosing schedules, increased use of GnRH analogues for radiation-induced precocious puberty, and a reduced time interval between completion of irradiation and initiation of GH therapy. When retested at the completion of growth, 80-90% of these teenagers are likely to prove severely GH deficient and, therefore, will potentially benefit from GH replacement in adult life. Such long-term GH treatment in patients treated previously for a brain tumor means that critical and continuous surveillance must be devoted to the risk of tumor recurrence and the possibility of second neoplasms.
CitationPathophysiology of radiation-induced growth hormone deficiency: efficacy and safety of GH replacement. 2006, 16 Suppl A:S30-40 Growth Horm. IGF Res.
JournalGrowth Hormone & IGF Research
- Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response.
- Authors: Svensson J, Finer N, Bouloux P, Bevan J, Jonsson B, Mattsson AF, Lundberg M, Harris PE, Koltowska-Häggström M, Monson JP, KIMS International Board.
- Issue date: 2007 Feb
- Hypopituitarism following Radiotherapy Revisited.
- Authors: Darzy KH, Shalet SM
- Issue date: 2009
- Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement.
- Authors: Gleeson HK, Stoeter R, Ogilvy-Stuart AL, Gattamaneni HR, Brennan BM, Shalet SM
- Issue date: 2003 Aug
- Growth hormone and the transition from puberty into adulthood.
- Authors: Attanasio AF, Shalet SM
- Issue date: 2007 Mar
- Growth hormone dosing variables in growth hormone-deficient adults.
- Authors: Cook DM, Yuen KC
- Issue date: 2006 Jul